Literature DB >> 16344672

Idiopathic hypereosinophilic syndrome in children: report of a 7-year-old boy with FIP1L1-PDGFRA rearrangement.

Susana Rives1, Iñaki Alcorta, Teresa Toll, Esperanza Tuset, Jesús Estella, Nicholas C P Cross.   

Abstract

Idiopathic hypereosinophilic syndrome (HES) in children is a very rare disorder; certain clinical differences with adult HES have been described, with no pediatric case with the imatinib-responsive FIP1L1-PDGFRA fusion gene reported to date. The authors describe the clinical course of three children with HES in whom FIP1L1-PDGFRA fusion gene was studied and report the first child with this rearrangement.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16344672     DOI： 10.1097/01.mph.0000193467.06938.77

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN： 1077-4114            Impact factor:   1.289


  5 in total

Review 1.  Advances in diagnosis and treatment of eosinophilia.

Authors:  Javed Sheikh; Peter F Weller
Journal:  Curr Opin Hematol       Date:  2009-01       Impact factor: 3.284

2.  Hypereosinophilia and severe bone disease in an African child: an unexpected diagnosis.

Authors:  Sofia Bota; Pedro Alves; Claudia Constantino; Raquel Maia
Journal:  BMJ Case Rep       Date:  2019-04-29

Review 3.  Eosinophilic disorders in children.

Authors:  Amy Wagelie-Steffen; Seema S Aceves
Journal:  Curr Allergy Asthma Rep       Date:  2006-11       Impact factor: 4.919

4.  The Spectrum of FIP1L1-PDGFRA-Associated Chronic Eosinophilic Leukemia: New Insights Based on a Survey of 44 Cases.

Authors:  Fanny Legrand; Aline Renneville; Elizabeth MacIntyre; Samuel Mastrilli; Felix Ackermann; Jean Michel Cayuela; Philippe Rousselot; Aline Schmidt-Tanguy; Olivier Fain; Marc Michel; Jean-Pierre de Jaureguiberry; Pierre-Yves Hatron; Pascale Cony-Makhoul; Didier Lefranc; Damien Sène; Vincent Cottin; Mohamed Hamidou; Olivier Lidove; André Baruchel; Sylvain Dubucquoi; Olivier Bletry; Claude Preudhomme; Monique Capron; Lionel Prin; Jean Emmanuel Kahn
Journal:  Medicine (Baltimore)       Date:  2013-09       Impact factor: 1.889

5.  Sustained Complete Molecular Remission With Imatinib Monotherapy in a Child Presenting With Blast Phase FIP1L1-PDGFRA-Associated Myeloid Neoplasm With Eosinophilia.

Authors:  Juhi Jain; Elizabeth P Weinzierl; Debra Saxe; John Bergsagel; Jason Gotlib; Andreas Reiter; Sunil S Raikar
Journal:  Hemasphere       Date:  2020-11-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.